Drug profile · INN
haemophilus b conjugate (meningococcal protein conjugate) and hepatitis b (recombinant) vaccine
PROCOMVAX
- Patents linked
- 0
- News articles
- 0
Quick answer
haemophilus b conjugate (meningococcal protein conjugate) and hepatitis b (recombinant) vaccine (PROCOMVAX) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN haemophilus b conjugate (meningococcal protein conjugate) and hepatitis b (recombinant) vaccine
Brand PROCOMVAX
ATC code J07CA
Frequently asked questions
What is haemophilus b conjugate (meningococcal protein conjugate) and hepatitis b (recombinant) vaccine?
haemophilus b conjugate (meningococcal protein conjugate) and hepatitis b (recombinant) vaccine (PROCOMVAX) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for haemophilus b conjugate (meningococcal protein conjugate) and hepatitis b (recombinant) vaccine?
PROCOMVAX is a marketed brand name for haemophilus b conjugate (meningococcal protein conjugate) and hepatitis b (recombinant) vaccine. Check FDA Drugs@FDA for the current US label holder and prescribing information.